Natural Killer T (NKT) cells are a specialized subset of T cells that recognize and respond to alterations in the lipid composition of dendritic cells, macrophages and other types of antigen presenting cells (APCs). They play a significant role in various disease processes, including cancer, allergy, autoimmunity and infection. NKT cells are typically induced by inflammatory cytokines, and are alerted to inflammation by specialized membrane glycoproteins called CD1d molecules. CD1d molecules bind lipids produced by the APCs and present them on the surface, where they are recognized by specific receptors on the NKT cells. When activated, NKT cells rapidly produce a range of cytokines that amplify the subsequent response made by conventional T cells and can determine the type of T cell response that occurs. The overarching goal of this proposal is to determine the parameters that determine the optimal response of NKT cells. In one aim we hypothesize, based on substantial preliminary data, that the glycan chains attached to the CD1d molecules interact with similar glycans on the NKT cell receptor and inhibit the responses of the NKT cells in the absence of inflammation. We will determine which glycans of the CD1d molecule and the NKT cell receptor interact to mediate this effect, and will also determine if modulation of the interaction plays a rle in the recognition of NKT cells in vivo and in vitro. Lipid association with CD1d molecules occurs in internal compartments of the cell called lysosomes, through which CD1d molecules repeatedly traffic from the cell surface. A second goal of the proposal is to understand this process in detail, specifically how lipid trafficking and degradation and CD1d trafficking are integrated to maximize the efficiency of the process. Cellular regulators of the internalization process called Rab GTPases will be assessed for their ability to generate the optimal compartment for lipid binding. Finally, to broaden the search for mechanisms that regulate lipid association we have completed a genetic screen that has revealed at least two novel genes that are required for the process. Determining the functions of these genes is expected to transform our understanding of the NKT cell response to CD1d interactions by identifying mechanisms that do not depend on preconceptions based on known biochemical and cell biological parameters. Ultimately, modulating the actions of these genes may lead to novel therapeutic approaches to the wide variety of diseases in which NKT cells play a role.

Public Health Relevance

CD1d molecules play a critical role in initiating appropriate T cell responses by activating NKT cells. Activated NKT cells have the potential for direct cytotoxicity and rapidly produce a variety of cytokines that can polarize subsequent CD4 T cell responses. Understanding the regulation of the CD1d/NKT interaction is of vital importance, and manipulating the NKT response has therapeutic potential for cancer, autoimmunity, allergic responses and infectious disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI059167-14
Application #
9433595
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Gondre-Lewis, Timothy A
Project Start
2004-02-01
Project End
2020-02-29
Budget Start
2018-03-01
Budget End
2019-02-28
Support Year
14
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Yale University
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
043207562
City
New Haven
State
CT
Country
United States
Zip Code
06520
Paduraru, Crina; Bezbradica, Jelena S; Kunte, Amit et al. (2013) Role for lysosomal phospholipase A2 in iNKT cell-mediated CD1d recognition. Proc Natl Acad Sci U S A 110:5097-102
Wen, Xiangshu; Rao, Ping; Carreno, Leandro J et al. (2013) Human CD1d knock-in mouse model demonstrates potent antitumor potential of human CD1d-restricted invariant natural killer T cells. Proc Natl Acad Sci U S A 110:2963-8
Kunte, Amit; Zhang, Wei; Paduraru, Crina et al. (2013) Endoplasmic reticulum glycoprotein quality control regulates CD1d assembly and CD1d-mediated antigen presentation. J Biol Chem 288:16391-402
Blum, Janice S; Wearsch, Pamela A; Cresswell, Peter (2013) Pathways of antigen processing. Annu Rev Immunol 31:443-73
Rao, Ping; Pham, Hong Thanh; Kulkarni, Arpita et al. (2011) Herpes simplex virus 1 glycoprotein B and US3 collaborate to inhibit CD1d antigen presentation and NKT cell function. J Virol 85:8093-104
Zhu, Yajuan; Zhang, Wei; Veerapen, Natacha et al. (2010) Calreticulin controls the rate of assembly of CD1d molecules in the endoplasmic reticulum. J Biol Chem 285:38283-92
Yuan, Weiming; Kang, Suk-Jo; Evans, James E et al. (2009) Natural lipid ligands associated with human CD1d targeted to different subcellular compartments. J Immunol 182:4784-91
Ricour, CĂ©line; Delhaye, Sophie; Hato, Stanleyson V et al. (2009) Inhibition of mRNA export and dimerization of interferon regulatory factor 3 by Theiler's virus leader protein. J Gen Virol 90:177-86
Yuan, Weiming; Qi, Xiaoyang; Tsang, Pansy et al. (2007) Saposin B is the dominant saposin that facilitates lipid binding to human CD1d molecules. Proc Natl Acad Sci U S A 104:5551-6
Paduraru, Crina; Spiridon, Laurentiu; Yuan, Weiming et al. (2006) An N-linked glycan modulates the interaction between the CD1d heavy chain and beta 2-microglobulin. J Biol Chem 281:40369-78

Showing the most recent 10 out of 11 publications